Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

(LAANTERN Trial)

Recruiting in Palo Alto (17 mi)

+28 other locations

Overseen by Eric Leuthardt, MD

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Monteris Medical

No Placebo Group

Trial Summary

What is the purpose of this trial?

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 1,000 patients and up to 50 sites.

Research Team

Eric Leuthardt, MD

Principal Investigator

Washington University School of Medicine

Eligibility Criteria

Inclusion Criteria

Subject or legally authorized representative provides written authorization and/or consent

Subject who is to undergo thermal therapy by the NeuroBlate® System for treatment of their neurological disorder

Treatment Details

Interventions

• Robotic NeuroBlate System (Procedure)

Who Is Running the Clinical Trial?

Monteris Medical

Lead Sponsor

Trials

10

Recruited

1,600+